Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting StentsA Subgroup Analysis of the SIRTAX Trial
Mario Togni, MD*,
Stéphanie Eber, BA*,
Jeannette Widmer, BA*,
Michael Billinger, MD*,
Peter Wenaweser, MD*,
Stéphane Cook, MD*,
Rolf Vogel, MD, PhD*,
Christian Seiler, MD, FACC*,
Franz R. Eberli, MD ,
Willibald Maier, MD ,
Roberto Corti, MD ,
Marco Roffi, MD ,
Thomas F. Lüscher, MD ,
Ali Garachemani, MD*,
Otto M. Hess, MD, FACC*,
Simon Wandel, MS ,
Bernhard Meier, MD, FACC*,
Peter Jüni, MD and
Stephan Windecker, MD*,*
* Departments ofCardiology
Social and Preventive Medicine, University Hospital Bern, Switzerland
Department of Cardiology, University Hospital Zurich, Zurich, Switzerland

View larger version (8K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Cumulative Event Curves of TLR Stratified for Stent Type
(A) Small vessels only; (B) large vessels only; (C) both small and large vessels (mixed). TLR = target lesion revascularization.
|
|
|